Cargando…
Immunotherapy associated central nervous system complications in primary brain tumors
Advances clarifying the genetics and function of the immune system within the central nervous system (CNS) and brain tumor microenvironment have led to increasing momentum and number of clinical trials using immunotherapy for primary brain tumors. While neurological complications of immunotherapy in...
Autores principales: | Mantica, Megan, Drappatz, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981156/ https://www.ncbi.nlm.nih.gov/pubmed/36874119 http://dx.doi.org/10.3389/fonc.2023.1124198 |
Ejemplares similares
-
Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020) -
Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
por: Qiu, Bo, et al.
Publicado: (2021) -
Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021) -
BRAF Alteration in Central and Peripheral Nervous System Tumors
por: Srinivasa, Komal, et al.
Publicado: (2020) -
Pathogenesis of central nervous system germ cell tumors
por: Liu, Siyuan, et al.
Publicado: (2022)